YZR Capital is a venture capital firm established in 2021 and located in Munich, Germany. The firm specializes in backing entrepreneurs in the health technology sector, with a broader investment focus that includes healthcare, artificial intelligence, big data, digital health, and robotics. YZR Capital primarily targets early-stage companies within the DACH region, emphasizing Germany. The firm aims to support innovations that enhance health care delivery and improve patient outcomes through advanced technology solutions.
Caire intends to revolutionize health monitoring by utilizing AI to extract vital signs and health diagnoses from facial recordings.
Vetnio
Pre Seed Round in 2024
Vetnio is a tool that records conversations between veterinary professionals and pet owners, automatically generating clinical notes for the meetings. It saves veterinary professionals time, allowing them to focus more on their patients.
Biorce
Seed Round in 2024
Biorce is an innovating HealthAI startup committed to transforming drug development through the use of artificial intelligence.
Univa Health
Pre Seed Round in 2024
Univa's objective is to provide evidence-based clinical tools that address the detrimental impact of eating disorder diseases on both the individual and their families.
Esper Bionics
Venture Round in 2024
Esper Bionics is a Ukrainian company founded in 2018 that specializes in the development of advanced prosthetics and human enhancement devices. The company focuses on creating bionic limbs and controllers, particularly its flagship product, the Esper Hand, which is a self-learning myoelectric hand prosthesis. Esper Bionics also offers the Esper Control, a wearable brain-computer interface, and the Esper Platform, a cloud-based software solution designed to customize the operation of these devices. By integrating technologies such as digital signal processing, artificial intelligence, and low-power electronics, the company aims to enhance the functionality and adaptability of its products, providing users with improved control and ease in daily activities. Their innovative approach includes features that allow bionic hands to automatically adjust grips, catering to a range of user needs.
Deemea
Seed Round in 2024
Deemea is a developer of a digital medical assistance platform tailored for clinical research and the analysis of real-life data. The company's AI-driven platform assists clinical research operators by streamlining the imaging data journey, enhancing efficiency and reliability. It utilizes artificial intelligence to identify suitable databases, expedites contractual and regulatory processes, and simplifies external model validation. Additionally, Deemea's platform optimizes responses to internal and external requests while valorizing real-world data and clinical studies. Through these capabilities, Deemea supports clients in accelerating the development and deployment of innovative projects that leverage AI tools specific to the valorization of medical data.
apoQlar
Series A in 2024
apoQlar is a developer of a medical mixed reality platform that aims to enhance the practice and education of medicine worldwide. Its flagship product, VSI HoloMedicine®, is a medically certified software platform that utilizes Microsoft HoloLens technology to convert medical images, clinical workflows, and educational content into an interactive three-dimensional mixed reality environment. This innovative approach is designed to improve patient outcomes, enrich the clinical experience for healthcare professionals, and provide advanced training for future physicians. By integrating cutting-edge technology into medical practices, apoQlar is setting a new standard in the healthcare industry.
Kalia Lab
Seed Round in 2024
Kalia Lab offers cosmetic and skin care services.
Open Health
Pre Seed Round in 2023
OPEN Health is a healthcare agency specializing in market access strategies and communications. The company offers a diverse range of services, including health economic modeling, patient engagement, real-world evidence, data analytics, and medical affairs consultancy. With a team of approximately 200 professionals, OPEN Health collaborates with leading pharmaceutical companies, as well as various medical device and healthcare delivery organizations, ranging from startups to large multinationals. By integrating scientific expertise with creative and digital solutions, the agency aims to enhance healthcare marketing and support organizations in focusing on their core functions.
Scan.com
Series A in 2023
Scan.com is a diagnostic imaging platform operating in both the UK and USA markets, aimed at enhancing accessibility to medical imaging services. The platform provides an online booking system that allows patients to arrange and pay for private scans according to their specific needs. Additionally, Scan.com functions as a medical referral service, connecting patients with diagnostic scanning centers. This service is designed to reduce long waiting times and minimize delays in both diagnosis and subsequent aftercare, thereby improving the overall patient experience in obtaining necessary medical imaging.
Holi
Pre Seed Round in 2023
Holi is a digital metabolic wellness clinic.It helps to treat Obesity, insulin resistance, type 2 diabetes, and heart diseases.
filu
Seed Round in 2023
Filu is a veterinary company that provides medical pet care. The company creates technologically advanced veterinary clinics for upcoming veterinarians and pet owners. Filu was established in 2022 in Berlin, Germany.
IQONIC.AI
Seed Round in 2023
Creating AI Solutions for Skin, Hair & Inner Balance
deepeye Medical
Seed Round in 2023
deepeye is a precision medicine platform focused on retinal diseases, specifically designed to enhance therapy outcomes for conditions such as Age-related Macular Degeneration (AMD). With a significant portion of the population in the EU and US affected by these diseases, deepeye aims to prevent blindness by enabling ophthalmologists to deliver tailored treatment plans. The platform utilizes artificial intelligence to analyze therapy data and develop deep learning models, providing valuable insights for pharmaceutical companies, payors, and healthcare providers. This technology supports ophthalmologists in offering individualized care, ensuring that patients receive the most effective interventions for their specific needs.
apoQlar
Venture Round in 2023
apoQlar is a developer of a medical mixed reality platform that aims to enhance the practice and education of medicine worldwide. Its flagship product, VSI HoloMedicine®, is a medically certified software platform that utilizes Microsoft HoloLens technology to convert medical images, clinical workflows, and educational content into an interactive three-dimensional mixed reality environment. This innovative approach is designed to improve patient outcomes, enrich the clinical experience for healthcare professionals, and provide advanced training for future physicians. By integrating cutting-edge technology into medical practices, apoQlar is setting a new standard in the healthcare industry.
Scan.com
Series A in 2023
Scan.com is a diagnostic imaging platform operating in both the UK and USA markets, aimed at enhancing accessibility to medical imaging services. The platform provides an online booking system that allows patients to arrange and pay for private scans according to their specific needs. Additionally, Scan.com functions as a medical referral service, connecting patients with diagnostic scanning centers. This service is designed to reduce long waiting times and minimize delays in both diagnosis and subsequent aftercare, thereby improving the overall patient experience in obtaining necessary medical imaging.
HAIR & SKIN
Series B in 2022
HAIR & SKIN offers hair transplants and autologus blood therapies at affordable prices.
uPacjenta
Seed Round in 2022
Upacjenta aims to promote preventive laboratory testing among Polish women and the broader Polish population. The company offers a healthcare platform that includes telemedicine services, online consultations, and medical interviews. In addition, Upacjenta provides home blood testing, travel research antigen testing, and point-of-collection testing services. By focusing on prevention rather than treatment, Upacjenta seeks to empower individuals to take charge of their health and well-being.
Clare&me
Pre Seed Round in 2022
Clare&me is an AI-driven audio bot designed to address mental health issues such as anxiety and mild depression. It offers users a platform to discuss their concerns through phone calls, WhatsApp, or SMS, ensuring 24/7 access to evidence-based self-help techniques. The AI assistant, Clare, facilitates users through reflective exercises and grounding techniques in a judgment-free and anonymous setting. By leveraging cognitive behavioral therapy principles, Clare&me aims to alleviate the challenges associated with accessing mental health support, making it available to individuals anytime and anywhere. This service operates on a subscription model, enhancing the accessibility and personalization of mental health care.
Mindsurance
Pre Seed Round in 2021
Mindsurance is a digital mental health platform that enables employees to access a variety of certified mental health services. Through its application, users can connect instantly with therapists, coaches, and digital tools designed to support mental well-being. The platform offers one-on-one sessions with psychologists and therapists, as well as anonymous reporting features to track usage and activity. By partnering with insurance companies to co-finance these services, Mindsurance aims to enhance employee health and promote a balanced state of mind in the workplace.
Scan.com
Pre Seed Round in 2021
Scan.com is a diagnostic imaging platform operating in both the UK and USA markets, aimed at enhancing accessibility to medical imaging services. The platform provides an online booking system that allows patients to arrange and pay for private scans according to their specific needs. Additionally, Scan.com functions as a medical referral service, connecting patients with diagnostic scanning centers. This service is designed to reduce long waiting times and minimize delays in both diagnosis and subsequent aftercare, thereby improving the overall patient experience in obtaining necessary medical imaging.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.